EUSEM 2026
Come find us at booth #10 in the exhibition area. We'll be demonstrating PMcardio and the Queen of Hearts AI, and we'd love to talk about how AI-powered ECG interpretation fits into the emergency workflow.
Paris, France
September 25–27, 2026
EUSEM is the largest annual gathering of emergency medicine professionals in Europe. Organised by the European Society for Emergency Medicine, the congress brings together more than 3,500 delegates — emergency physicians, trainees, nurses, paramedics and EM technicians — from across Europe and beyond for a full scientific programme of over 90 sessions and 250 expert speakers.
The programme spans the entire acute care chain, from pre-hospital response to the emergency department, with a strong emphasis on practice-changing research, hands-on workshops and team-based simulation events such as the SIM Cup and Paramedics Cup. It's a natural home for anyone working on faster, more accurate diagnosis at the front door of the hospital.
Pre-courses run on 23–24 September, ahead of the main congress.
- Venue: Palais des Congrès de Paris, 2 Place de la Porte Maillot, Paris, France
- Organiser: European Society for Emergency Medicine (EUSEM)
- Website: eusemcongress.org
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.